Community and ambulatory pharmacy: Evaluation of patient care services and billing patterns before implementation of Medicare Part D

Journal of the American Pharmacists Association

Volumn 46, Issue 6, 2006, Pages 707-714

  Beatty, Stuart J ^a   Rodis, Jennifer L ^a   Bellebaum, Katherine L ^a   Mehta, Bella H ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

Ambulatory care; Community and ambulatory pharmacy; Disease management; Medication therapy management; Pharmaceutical care; Pharmacy services; Reimbursement

Indexed keywords

AMBULATORY CARE; ANTICOAGULATION; BILLING AND CLAIMS; COMMUNITY CARE; COMPARATIVE STUDY; CONTROLLED STUDY; DIABETES MELLITUS; DYSLIPIDEMIA; E-MAIL; HEALTH SERVICE; HEALTH SURVEY; HUMAN; HYPERTENSION; MEDICAL PRACTICE; MEDICAL SOCIETY; MEDICARE; OUTCOME ASSESSMENT; PATIENT CARE; PHARMACIST; PHARMACY; PHYSICIAN; PREVALENCE; REVIEW; SMOKING CESSATION; UNITED STATES;

EID: 33845922274     PISSN: 15443191     EISSN: 15443450     Source Type: Journal    
DOI: 10.1331/1544-3191.46.6.707.Beatty     Document Type: Article

References (38)

1. Lee YP, Schommer JC. Effect of a pharmacist-managed anticoagulation clinic on warfarin-related hospital readmissions. Am J Health Syst Pharm. 1996;53:1580-3.
2. Chamberlain MA, Sageser NA, Ruiz D. Comparison of anticoagulation clinic patient outcomes with outcomes from traditional care in a family medicine clinic. J Am Board Fam Prac. 2001;14:16-21.
3. Chiquette E, Amato MG, Bussey HI. Comparison of an anticoagulation clinic with usual medical care: anticoagulation control, patient outcomes, and health care costs. Arch Intern Med. 1998;158:1641-7.
4. Cranor CW, Christensen DB. The Asheville Project: short-term outcomes of a community pharmacy diabetes care program. J Am Pharm Assoc. 2003;43:149-59.
5. Cranor CW, Bunting BA, Christensen DB. The Asheville Project: long-term clinical and economic outcomes of a community pharmacy diabetes care program. J Am Pharm Assoc. 2003;43:173-84.
6. Garrett DG, Bluml BM. Patient Self-Management Program for Diabetes: first-year clinical, humanistic, and economic outcomes. J Am Pharm Assoc. 2005;45:130-7.
7. Bluml BM, McKenney JM, Cziraky MJ. Pharmaceutical care services and results in Project ImPACT; Hyperlipidemia. J Am Pharm Assoc. 2000;40:157-65.
8. Olson KL, Rasmussen J, Sandhoff BG, Merenich JA. Lipid management in patients with coronary artery disease by a clinical pharmacy service in a group model health maintenance organization. Arch Intern Med. 2005;165:49-54.
9. Tsuyuki RT, Johnson JA, Teo KK, et al. A randomized trial of the effect of a community pharmacist intervention on cholesterol risk management: the Study of Cardiovascular Risk Intervention by Pharmacists (SCRIP). Arch Inter Med. 2002;162:1149-55.
10. Morton MR, Spruill WJ, Cooper JW. Pharmacist impact on pneumococcal vaccination rates in long-term-care facilities. Am J Hosp Pharm. 1988;45:73.
11. Ernst ME, Chalstrom CV, Currie JD, Sorofman B. Implementation of a community pharmacy-based influenza vaccination program. J Am Pharm Assoc. 1997;NS37:570-80.
12. Gattis WA, Hasselblad V, Whellan DJ, O'Connor CM. Reduction in heart failure events by the addition of a clinical pharmacist to the heart failure management team: results of the Pharmacist in Heart Failure Assessment Recommendation and Monitoring (PHARM) Study. Arch Intern Med. 1999;159:1939-45.
13. Suchanek-Hudmon K, Hemberger KK, Corelli RL, et al. The pharmacist's role in smoking cessation counseling: perception of users of nonprescription nicotine replacement therapy. J Am Pharm Assoc. 2003;43:573-82.
14. Goode JV, Swiger K, Bluml BM. Regional osteoporosis screening, referral, and monitoring program in community pharmacies: findings from Project ImPACT: Osteoporosis. J Am Pharm Assoc. 2004;44:152-60.
15. Jameson J, VanNoord G, Vanderwoud K. The impact of a pharmacotherapy consultation on the cost and outcome of medical therapy. J Fam Pract. 1995;41:469-72.
16. Chrischilles EA, Carter BL, Lund BC, et al. Evaluation of the Iowa Medicaid pharmaceutical case management program. J Am Pharm Assoc. 2004;44:337-49.
17. Sterné SC, Gundersen BP, Shrivastava D. Development and evaluation of a pharmacist-managed asthma education clinic. Hosp Pharm. 1999;34:699-706.
18. Rupp MT, McCallian DJ, Sheth KK. Developing and marketing a community pharmacy-based asthma management program. J Am Pharm Assoc. 1997;NS37:694-99.
19. Bunting BA, Cranor CW. The Asheville Project: long-term clinical, humanistic, and economic outcomes of a community-based medication therapy management program for asthma. J Am Pharm Assoc. 2006;46:133-47.
20. Vivian EM. Improving blood pressure control in a pharmacist-managed hypertension clinic. Pharmacotherapy. 2002;22:1533-40.
21. Chabot I, Moisan J, Grégoire JP, Milot A. Pharmacist intervention program for control of hypertension. Ann Pharmacother. 2003;37:1186-93.
22. Bennett M, Jacobson-Wedret J, eds. Building a successful collaborative pharmacy practice: guidelines and tools. Washington, D.C.: American Pharmacists Association; 2004.
23. Blair MM, Blake EW, Harris IM. Ambulatory care survival guide. Kansas City: American College of Clinical Pharmacy; 2004.
24. Rovers JP, Currie JD, Hagel HP, et al., eds. A practical guide to pharmaceutical care. 2nd ed. Washington, D.C.: American Pharmaceutical Association; 2003.
25. American Pharmacists Association. Diabetes management services: a pharmacist's resource guide. Washington, D.C.: American Pharmacists Association; 2004.
26. Gardner JS. A practical guide to establishing vaccine administration services in community pharmacies. J Am Pharm Assoc. 1997;NS37:683-93.
27. Weitzel KW, Goode JV. Implementation of a pharmacy-based immunization program in a supermarket chain. J Am Pharm Assoc. 2000;40:252-6.
28. Snella KA, Sachdev GP. A primer for developing pharmacist-managed clinics in the outpatient setting. Pharmacotherapy. 2003;23:1153-66.
29. Kuo GM, Buckley TE, Fitzsimmons DS, Steinbauer JR. Collaborative drug therapy management services and reimbursement in a family medicine clinic. Am J Health Syst Pharm. 2004;61:343-54.
30. McDonough RP, Rovers JP, Currie JD, et al. Obstacles to the implementation of pharmaceutical care in the community setting. J Am Pharm Assoc. 1998;38:87-95.
31. Medicare Prescription Drug, Improvement, and Modernization Act of 2003. H.R.1. Accessed at www.cms.hhs.gov/EmplUnionPlanSponsorInfo/ downloads/hr1.pdf, October 17, 2006.
32. Bluml BM. Definition of medication therapy management: development of professionwide consensus. J Am Pharm Assoc. 2005;45:566-72.
33. American Pharmacists Association and National Association of Chain Drug Stores Foundation. Medication therapy management services in community pharmacy: planning for successful implementation-a practical guide for community pharmacists. Washington, D.C.: American Pharmacists Association; 2005.
34. American Pharmacists Association and National Association of Chain Drug Stores Foundation. Medication therapy management in community pharmacy practice: core elements of an MTM service (version 1.0). J Am Pharm Assoc. 2005;45:573-9.
35. The Lewin Group. Medication therapy management services: a critical review. J Am Pharm Assoc. 2005;45:580-7.
36. Snella KA, Trewyn RR, Hansen LB, Bradberry JC. Pharmacist compensation for cognitive services: focus on the physician office and community pharmacy. Pharmacotherapy. 2004;24:372-88.
37. Speer A, Bess DT. Evaluation of compensation of nonphysician providers. Am J Health Syst Pharm. 2003;60:78-80.
38. Bennett MS, Blank D, Bopp J, et al. Strategies to improve compensation for pharmaceutical care services. J Am Pharm Assoc 2000;40:747-55.